Kaufmann will be responsible for the company's drug discovery, protein engineering
and biomanufacturing activities, while overseeing alliance management and serving as site head for its German R&D facility.
is a privately held biotechnology software company offering scientific consulting services and the Cyrus Bench[R] SaaS platform for protein engineering
to accelerate discovery of biologics and small molecules for the Biotechnology, Pharmaceutical, Chemical, Consumer Products and Synthetic Biology industries.
The company is working to develop pesticide-free cannabis using protein engineering
methods that break-down and detoxify organophosphates, a commonly used pesticide.
is a privately held biotechnology software company offering scientific consulting services and the Cyrus Bench SaaS platform for protein engineering
to accelerate discovery of biologics and small molecules for the biotechnology, Pharmaceutical, Chemical, Consumer Products and Synthetic Biology industries.
M2 PRESSWIRE-August 8, 2019-: Worldwide Protein Engineering
Markets to 2025 - Projecting a CAGR of 15.8% During 2019-2025
The team used protein engineering
software to design proteins that bind to each other, so they form a fractal, tree-like shape in response to biological stimuli, such as in a cell, tissue or organism.
Previously, Dr Hayes has worked as vice president & venture leader of Centyrex, a biotech Venture within Janssen R&D, as well as senior director of Protein Engineering
at Johnson & Johnson and Director of Antibody Engineering at Xencor.
Inhibrx utilizes diverse methods of protein engineering
to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform.
"We're at a technology transition point from modifying what exists in nature, which has been the traditional approach to protein engineering
, to using first principles to build proteins from scratch to have exactly the properties you want," said David Baker, the Henrietta and Aubrey Davis Endowed Professor of Biochemistry at the University of Washington School of Medicine, a Howard Hughes Medical Institute investigator, and the founder and director of IPD.
Geneious and Biomatters empowers its customers with software that transforms biological data into knowledge and actionable insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering
and advanced comparative analysis of DNA, RNA and protein sequences.
In addition to her role as NYU Tandon professor and head of theMontclare Lab for Protein Engineering
and Molecular Design, Montclare serves as the director of the school's Convergence for Innovation and Entrepreneurship Institute and associate director for technology advancement atNew York University'sMaterials Research Science and Engineering Center (MRSEC).